MX9706627A - Derivado de tiazolidinona opticamente activo. - Google Patents
Derivado de tiazolidinona opticamente activo.Info
- Publication number
- MX9706627A MX9706627A MX9706627A MX9706627A MX9706627A MX 9706627 A MX9706627 A MX 9706627A MX 9706627 A MX9706627 A MX 9706627A MX 9706627 A MX9706627 A MX 9706627A MX 9706627 A MX9706627 A MX 9706627A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- optically active
- effect
- thiazolidinone derivatives
- active thiazolidinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Soil Working Implements (AREA)
- Supplying Of Containers To The Packaging Station (AREA)
Abstract
Un derivado de tiazolidinona opticamente activo que tiene la formula general (I): en donde Rü representa un átomo de hidrogeno, un grupo alquilo de C1-C4, un grupo fenilo, un grupo fenilo substituido (dicho substituyente representa alquilo de C1-C4, alcoxi de C1-C4 o halogeno), un grupo fenilalquilo de C1-C2 o un grupo fenilalquilo de C1-C2 substituido (el substituyente de dicho fenilo representa alquilo de C1-C4, alcoxi de C1-C4 o halogeno) R² representa un grupo alquilo de C1-C6; y n representa 1 o 2; el derivado de tiazolidinona opticamente activo de la presente invencion tiene tiazolidinona opticamente activo de la presente invencion tiene excelente accion contra angina de pecho y es util como un agente preventivo o un agente terapéutico para angina de pecho.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7-42237 | 1995-03-02 | ||
JP4223795 | 1995-03-02 | ||
JP7/42237 | 1995-03-02 | ||
JP7-279951 | 1995-10-27 | ||
JP7/279951 | 1995-10-27 | ||
JP27995195 | 1995-10-27 | ||
PCT/JP1996/000487 WO1996026931A1 (fr) | 1995-03-02 | 1996-03-01 | Derives de thiazolidinone optiquement actifs |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9706627A true MX9706627A (es) | 1997-11-29 |
MXPA97006627A MXPA97006627A (es) | 1998-07-03 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
CA2214386A1 (en) | 1996-09-06 |
CN1183096A (zh) | 1998-05-27 |
ATE201402T1 (de) | 2001-06-15 |
NO974004D0 (no) | 1997-09-01 |
KR100292737B1 (ko) | 2001-09-17 |
HU223094B1 (hu) | 2004-03-29 |
AU4843896A (en) | 1996-09-18 |
HUP9900320A3 (en) | 1999-11-29 |
CA2214386C (en) | 2001-12-04 |
NO309525B1 (no) | 2001-02-12 |
WO1996026931A1 (fr) | 1996-09-06 |
GR3036029T3 (en) | 2001-09-28 |
EP0812835A1 (en) | 1997-12-17 |
RU2141956C1 (ru) | 1999-11-27 |
PT812835E (pt) | 2001-08-30 |
DE69612967T2 (de) | 2002-04-04 |
NO974004L (no) | 1997-11-03 |
EP0812835B1 (en) | 2001-05-23 |
DE69612967D1 (en) | 2001-06-28 |
HK1003890A1 (en) | 1998-11-13 |
DK0812835T3 (da) | 2001-07-09 |
HK1016579A1 (en) | 1999-11-05 |
EP0812835A4 (en) | 1998-04-29 |
AU701977B2 (en) | 1999-02-11 |
NZ302391A (en) | 1999-04-29 |
CZ273497A3 (cs) | 1998-02-18 |
ES2158290T3 (es) | 2001-09-01 |
CN1066725C (zh) | 2001-06-06 |
KR19980702707A (ko) | 1998-08-05 |
CZ290989B6 (cs) | 2002-11-13 |
HUP9900320A2 (hu) | 1999-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2396738A1 (en) | Thiazole derivatives as active superoxide radical inhibitors | |
DK0641355T3 (da) | Anvendelse af sulfamatderivater som steroid-sulfatase-inhibitorer | |
NL1002835A1 (nl) | Synergistisch stabilisatormengsel. | |
NO20013379D0 (no) | 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler | |
TR200000333T2 (tr) | Y alıcı antagonistleri olarak 4-aminopirol (3,2-d) pirimidinler. | |
EP1130016A4 (en) | DERIVATIVES OF THIOCARBAMATE ACID | |
EP0640586A4 (en) | STILBENE DERIVATIVE AND STILBENE ANALOG DERIVATIVE, AND USE OF SUCH DERIVATIVES. | |
PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
NZ313185A (en) | 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives | |
WO1999000373A8 (fr) | Derives de benzimidazole | |
LU92263I2 (fr) | Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION) | |
ATE172463T1 (de) | Pyrrolocarbazol | |
AU5699494A (en) | Novel liquid phenolic antioxidants | |
TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
IL139013A0 (en) | Pyrazolinone derivatives | |
NZ326675A (en) | Oxazoline arthropodicides | |
NZ336091A (en) | Aqueous disinfecting cleaning composition | |
CA2244621A1 (en) | 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists | |
MX9706627A (es) | Derivado de tiazolidinona opticamente activo. | |
AU8143087A (en) | 2 - aminoacetamide derivatives | |
NZ333854A (en) | Intermediates for the preparation of 2-imidazoline-5-ones | |
MX9700497A (es) | Derivado de acido trifluorometilquinolinocarboxilico. | |
DK0788472T3 (da) | Fremgangsmåde til fremstilling af 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalenderivater | |
AP2001002314A0 (en) | Substituted benzolactam compounds. | |
DK0779895T3 (da) | Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider |